An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where communities with numerous of participants share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Material Elimination
According to TikTok, the service has removed problematic material and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, positive reviews and detailed instructions for preparing or administering at residence.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Item Details and Costs
Within these groups, posts show black plastic parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant health risks”.
